The White House has withdrawn Heidi Overton’s nomination to become the next Food and Drug Administration commissioner before the Senate Health, Education, Labor and Pensions Committee was due to consider her on Wednesday.
“Can confirm nomination pulled,” a White House official told the Washington Examiner on Tuesday.
A physician and deputy director of the White House Domestic Policy Council, President Donald Trump nominated Overton to replace acting Commissioner Kyle Diamantas after his predecessor, Marty Makary, was pushed out in May.
Overton has been criticized by supporters of Health and Human Services Secretary Robert F. Kennedy Jr.‘s MAHA movement for not helping with his priorities and instead helping the health and agriculture industry.
Anti-abortion activists have also scrutinized her perceived lack of commitment to more rules and regulations restricting access to the abortion pill mifepristone.
SEAN DUFFY SIDESTEPS RESPONSIBILITY FOR GROUND STOP AS FINGERS POINT TO FAA ADMINISTRATOR
HELP Chairman Bill Cassidy (R-LA), amplifying the complaints of Democrats on the committee, has expressed “strong concerns” about Overton’s role in the administration’s reforms to childhood vaccine recommendations, which he called “almost disqualifying.”
Makary had earlier been under pressure for declining to align with the White House and administration’s desire to authorize fruit-flavored electronic cigarettes because the sweet flavors could appeal to children, in addition to criticism he, too, was delaying restrictions on online prescriptions for mifepristone, amid other tension points.
